Lincoln National Corp lifted its position in Stryker Corporation (NYSE:SYK) by 8.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,368 shares of the medical technology company’s stock after purchasing an additional 181 shares during the quarter. Lincoln National Corp’s holdings in Stryker Corporation were worth $329,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in SYK. BlackRock Inc. raised its position in Stryker Corporation by 2,526.4% during the first quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock valued at $2,893,242,000 after acquiring an additional 21,140,000 shares in the last quarter. Vanguard Group Inc. raised its position in Stryker Corporation by 5.2% during the first quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock valued at $3,083,382,000 after acquiring an additional 1,161,688 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Stryker Corporation by 41.9% during the first quarter. PNC Financial Services Group Inc. now owns 1,403,420 shares of the medical technology company’s stock valued at $184,759,000 after acquiring an additional 414,715 shares in the last quarter. SG Americas Securities LLC raised its position in Stryker Corporation by 600.6% during the first quarter. SG Americas Securities LLC now owns 412,340 shares of the medical technology company’s stock valued at $54,285,000 after acquiring an additional 353,486 shares in the last quarter. Finally, Morgan Stanley raised its position in Stryker Corporation by 17.9% during the first quarter. Morgan Stanley now owns 2,144,472 shares of the medical technology company’s stock valued at $282,320,000 after acquiring an additional 325,661 shares in the last quarter. Hedge funds and other institutional investors own 74.13% of the company’s stock.

SYK has been the subject of several recent research reports. Piper Jaffray Companies reiterated an “overweight” rating and set a $148.00 price target on shares of Stryker Corporation in a research report on Thursday, August 24th. Needham & Company LLC upgraded Stryker Corporation from an “underperform” rating to a “hold” rating in a research report on Friday, August 25th. Cantor Fitzgerald initiated coverage on Stryker Corporation in a research report on Thursday, June 29th. They set a “neutral” rating and a $153.00 price target for the company. Morgan Stanley reiterated an “overweight” rating and set a $160.00 price target (up from $155.00) on shares of Stryker Corporation in a research report on Monday, July 10th. Finally, Zacks Investment Research upgraded Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price target for the company in a research report on Monday, July 17th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $145.73.

TRADEMARK VIOLATION WARNING: “Stryker Corporation (SYK) Shares Bought by Lincoln National Corp” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/09/19/stryker-corporation-syk-shares-bought-by-lincoln-national-corp.html.

Shares of Stryker Corporation (NYSE SYK) opened at 144.53 on Tuesday. The stock has a 50 day moving average price of $143.68 and a 200-day moving average price of $138.88. The firm has a market capitalization of $54.06 billion, a price-to-earnings ratio of 32.26 and a beta of 0.81. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $148.84.

Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. During the same period in the prior year, the business posted $1.39 EPS. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts anticipate that Stryker Corporation will post $6.46 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. This represents a $1.70 annualized dividend and a yield of 1.18%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is currently 37.95%.

In related news, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the transaction, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders sold a total of 25,429 shares of company stock valued at $3,686,927 over the last ninety days. 7.40% of the stock is currently owned by company insiders.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.